Academia.edu no longer supports Internet Explorer.
To browse Academia.edu and the wider internet faster and more securely, please take a few seconds to upgrade your browser.
2017
1. Chronic Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran 2. Elderly Health Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran 3. Metabolic Disorders Research Center, Endocrinology and Metabolism Molecular -Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran 4. Diabetes Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran 5. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
Scientific reports
Diabetes in Iran: Prospective Analysis from First Nationwide Diabetes Report of National Program for Prevention and Control of Diabetes (NPPCD-2016)2017 •
We estimated proportions of different types of diabetes, comorbidities, treatment (the use of oral glucose-lowering agents and insulin), control (hyperglycemia, dyslipidemia and hypertension) and chronic microvascular and macrovascular complications among people with diabetes presenting to the tertiary-care academic diabetes outpatient clinics in Iran. This study is the prospective analysis of data (n = 30,202) from the registry of university-affiliated adult outpatient diabetes clinics in the country during 2015-2016. The proportions of type 1 diabetes, types 2 diabetes, and other types of diabetes were 11.4%, 85.5%, and 1.3%, respectively. The frequencies of drug-naivety, use of oral agents, insulin monotherapy and insulin combination therapy were 2.9%, 60.5%, 11.5%, and 25.1%, respectively. Around 13.2%, 11.9% and 43.3% of patients with diabetes had controlled hyperglycemia, hyperlipidemia and hypertension, respectively. The proportions of retinopathy, nephropathy, peripheral neu...
Journal of Diabetes & Metabolic Disorders
Iran Diabetes Research Roadmap (IDRR): the study protocol2016 •
Iranian Journal of Public Health
Iran Diabetes Research Roadmap (IDRR) Study; Gap Analysis of Diabetes Complications in Iran: A Review Article2017 •
Background: Diabetes mellitus (DM) is a common non-communicable diseases associated with different complications. The study aim was to analyze and report characteristics of research output in the field of diabetes complication in Iran in details and identify research gap in this field. Methods: All scientific diabetes output published by Iranian authors in national and international journals until 2015 was included and analyzed. National and international databases including PubMed, Web of Science, SCOPUS, SID, IranMedex, and Magiran were searched. The obtained results were categorized into eleven subgroups. of complications, comorbidities, management, psychiatry, nutrition, prevention, physical activity, genetics, basic sciences, education and gestational diabetes mellitus (GDM). In each category, documents were classified based on the study design and topic as well as WHO and Australian National Health and Medical Research Council (NHMRC) classification. Results: After screening, ...
Iranian Journal of Public Health
Iran Diabetes Research Roadmap (IDRR) Study; Knowledge Gap in Ge-netic Research on Diabetes Mellitus in Iran: A Review Article2017 •
Background: Diabetes mellitus (DM) is the most common metabolic disorder worldwide. This study aimed to report characteristics of genetic studies in DM in Iran and to identify knowledge gap in genetics of diabetes in Iran. Methods: All publications of Iranian authors in national and international journals up to 2015 were included. Comprehensive search was performed in PubMed, Web of Science, Scopus, SID, IranMedex and Magiran using "Diabetes mellitus" and "Iran*" keywords and their combination. This search obtained 25589 documents. The obtained documents were categorized into eleven groups of complications, comorbidity, management, psychology, nutrition, physical activity, genetics, basic sciences, prevention, education and gestational diabetes mellitus (GDM). Documents were categorized based on publication year, WHO and Australian National Health and Medical Research Council (NHMRC) classification, study design and subject area. Results: After screening, 293 doc...
Journal of Diabetes & Metabolic Disorders
Iran diabetes research roadmap (IDRR) study: a preliminary study on diabetes research in the world and Iran2017 •
Eastern Mediterranean Health Journal
The diabetes prevention and control programme of the Islamic Republic of Iran2003 •
Diabetes mellitus has become a monumental problem and a major health concern throughout the world. We report on the programme developed by the Islamic Republic of Iran for control and management of diabetes, which involves screening for type 2 diabetes in adults at risk and a systematic approach for delivery of health care to people with diabetes
Journal of Natural Science, Biology and Medicine
Effective factors in controlling diabetes progression among patients in the northwest of Iran2016 •
OBJECTIVE-Despite concerns regarding a diabetes epidemic in the Middle East, internationally published data on national estimates of prevalent type 2 diabetes in Iran do not exist. With this article, we document a dramatically high prevalence of diabetes in Iran. RESEARCH DESIGN AND METHODS-Our data are based on the results of the first Survey of Risk Factors of Non-Communicable Diseases of Iran, 2005. In this national cross-sectional survey, 70,981 Iranian citizens aged 25-64 years were recruited. RESULTS-We found that 7.7% of adults aged 25-64 years, or 2 million adults, have diabetes, among whom one-half are undiagnosed. An additional 16.8%, or 4.4 million, of Iranian adults have impaired fasting glucose. CONCLUSIONS-The high prevalence of diabetes in working-age adults is an ominous sign for this developing nation. As the relatively young Iranian population ages in the future and urbanization continues or accelerates, the prevalence of diabetes will likely escalate. Diabetes Care 31:96-98, 2008 T he Middle East is expected to bear one of the world's greatest increases in the absolute burden of diabetes in the coming decades. Most of this increase is anticipated to affect the economically productive 45-to 64-year-old age segment in contrast with most developed countries, where the increase in diabetic patients will occur in those aged 65 years (1). Although national estimates of the diabetes burden in Iran do not exist, the most recent study reported a high prevalence of diabetes in the highly urbanized population of Tehran, Iran's capital. (2) Here, we report the diabetes-related results of the national Survey of Risk Factors of Non-Communicable Diseases (SURFNCD) of Iran. As a population based sample of over 89,000 Iranians, this study provides an opportunity to estimate the national prevalence and burden of impaired fasting glucose (IFG) and diabetes. As such, it provides a valuable basis for public health planning. RESEARCH DESIGN AND METHODS-The first Iran SUR-FNCD, a nationally representative cross-sectional health survey, was conducted in January and February 2005 using guidelines of the stepwise approach to non-communicable disease risk factor surveillance of the World Health Organization (3,4). In brief, a multistage probability cluster sampling scheme was used to randomly sample 89,400 adults aged 15-64 years from the urban and rural noninstitutionalized population of all 28 provinces of Iran. Participants were interviewed and examined to determine demographic characteristics and medical conditions, including history of diabetes. Participants who reported a history of physician-or health care professional-diagnosed diabetes were classified to have known diabetes. Subsequently, all participants aged 25-64 years (70,981 individuals) were asked to attend a health facility or laboratory for collection of blood samples following a 12-h fast. The departments of laboratory and medical diagnoses of each corresponding medical university in the provinces selected the laboratories based on standard instructions. The laboratories measured fasting plasma glucose (FPG) with coefficients of variation 3%. Of the 89,440 respondents, 18,459 individuals were aged 25 years, and of the remaining 70,981 individuals, 53,508 (75.4%) participated in the biochemical examination. Blood specimens were collected and handled under standard conditions. After excluding 406 (0.7%) subjects who did not fast and another 871 (1.6%) with invalid blood samples, FPG was measured in 52,231 individuals. In those without known diabetes, subjects with FPG 126 mg/dl were regarded as newly diagnosed diabetic case subjects. Those without known diabetes with FPG levels 100 mg/dl (5.6 mmol/l) but 126 mg/dl (7.0 mmol/l) were designated as having IFG (5). Data were analyzed considering the cluster and design effects using STATA, A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.
Iranian journal of diabetes and obesity
Prevalence of Complications of Diabetes and Risk Factors Among Patients with Diabetes in the Diabetes Clinic in Southeast of IranObjective: Academic health services play an important role in the prevention and control of diabetes mellitus (DM) in Iran. This study aimed at determining the prevalence of DM-related complications and the associated risk factors among patients with DM in a university-affiliated outpatient diabetes clinic of a referral hospital in Southeast of Iran, Zahedan. Materials and Methods: This cross-sectional study was conducted from January to April 2019 in an academic diabetes clinic. A total of 334 patients with DM, whose characteristics (age, sex, family history of DM, and substance abuse), as well as laboratory and clinical information, were recorded in the baseline forms, were included. The relationship between variables were assessed by Pearson’s correlation coefficient at P-value< 0.05 and using SPSS version 20.0. Results: The mean age of the participants was 54.27 (±11.57) years. In these patients, DM type 2 was estimated at 99.1%, and the mean duration of the disease was 8.98 ...
Sociedad del riesgo y expansión del derecho penal. Homenaje a Mirentxu Corcoy.
(2023)Repensando la importancia de la lógica formal para la valoración de la prueba penal2023 •
Evidence of fbi Atrocities Unveiled
Evidence of fbi Atrocities Unveiled. (author of "https://www.bigbrotherwatchingus.com/official-mind-control-patents.html" unknown)2020 •
Revista de Estudios Sociales
Vicarious Resilience: A Comprehensive Review2018 •
PHARMACON
Faktor Penyebab Medication Error Pada Pelayanan Kefarmasian Rawat Inap Bangsal Anak Rsud Tobelo2019 •
Frontiers in Psychology
Examining the effects of pleasantness ratings on correct and false recognition in the DRM paradigm: accuracy, recollection and familiarity estimates2024 •
Kidney International
Pleiotropic effects of the non-calcium phosphate binder sevelamer2006 •
Research Square (Research Square)
IoT and Blockchain for Smart Water Quality Management in Future Cities: A Hyperledger Fabric Framework for Smart Water Quality Management and Distribution2023 •
Journal of Function Spaces
Iterative Approximation of Fixed Point of Multivalued ρ-Quasi-Nonexpansive Mappings in Modular Function Spaces with Applications2018 •
International Journal of Computational Intelligence Systems
Recognizing Beehives’ Health Abnormalities Based on Mobile Net Deep Learning Model2016 •
arXiv (Cornell University)
AnyLoss: Transforming Classification Metrics into Loss Functions2024 •
Journal of Applied Sciences and Environmental Management
Spatial Variation of Reservoir Properties in Onshore Dove Field of the Niger Delta Region, Nigeria2020 •